Uric Acid Reduction: A New Paradigm in the Management of Cardiovascular Risk?

By  

Current Medicinal Chemistry, Vol. 14, Iss. 17, 2007-07 ,pp. : 1879-1886

Bentham Science Publishers

Access to resources Recommend Favorite

The uric acid metabolism pathway as a therapeutic target in hyperuricemia related to metabolic syndrome

By Simão Andréa Name Colado   Lozovoy Marcell Alysson Batisti   Dichi Isaias  

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 12, 2012-12 ,pp. : 1175-1187

Informa Healthcare

Access to resources Recommend Favorite

Serum Uric Acid and Risk of Coronary Heart Disease

By  

Current Pharmaceutical Design, Vol. 11, Iss. 32, 2005-12 ,pp. : 4125-4132

Bentham Science Publishers

Access to resources Recommend Favorite

Discovery of Flexible Naphthyltriazolylmethane-based Thioacetic Acids as Highly Active Uric Acid Transporter 1 (URAT1) Inhibitors for the Treatment of Hyperuricemia of Gout

By  

Medicinal Chemistry, Vol. 13, Iss. 3, 2017-04 ,pp. : 260-281

Bentham Science Publishers

Access to resources Recommend Favorite

Reducing uric acid as a means to prevent cardiovascular and renal disease

By Watanabe Susumu   Kanellis John   Nakagawa Takahiko   Han Lin   Ohashi Ryuji   Lan Hui   Feng Lili   Johnson Richard J  

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 2, 2002-02 ,pp. : 193-199

Informa Healthcare

Access to resources Recommend Favorite